×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Sotera Health Company (SHC) NASDAQ

$16.19 0.06 (0.37%)

Market Cap: $4.59B

As of 09/11/24 04:00 PM EDT. Market closed.

(SHC)

Sotera Health Company (SHC)
NASDAQ

$16.19
0.06 (0.37%)

Market Cap: $4.59B

As of 09/11/24 04:00 PM EDT. Market closed.

Add to Portfolio

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves ... read more

COMPANY PROFILE
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Michael B. Petras Jr.
Full Time Employees
3,000
CEO Compensation (Base)
$1.05M
CEO Compensation (Total)
$9.70M
URL
Address
9100 South Hills Boulevard, OH, Broadview Heights, 44147.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Michael B. Petras Jr.
Full Time Employees
3,000
CEO Compensation (Base)
$1.05M
CEO Compensation (Total)
$9.70M
Address
9100 South Hills Boulevard, OH, Broadview Heights, 44147.
PRICE CHART FOR SOTERA HEALTH COMPANY
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$16.83
Previous Close
$16.13
Days Range
$15.83 - $16.83
52 week range
$10.71 - $17.44
Volume
877,467
Avg. Volume (30 days)
1,292,372
Market Cap
$4.59B
Dividend Yield
-
P/E
115.64
Shares Outstanding
283,214,000
Open
$16.83
Previous Close
$16.13
Days Range
$15.83 - $16.83
52 week range
$10.71 - $17.44
Volume
877,467
Avg. Volume (30 days)
1,292,372
Market Cap
$4.59B
Dividend Yield
-
P/E
115.64
Shares Outstanding
283,214,000
FINANCIAL STATEMENTS FOR SOTERA HEALTH COMPANY
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SOTERA HEALTH COMPANY
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
WARBURG PINCUS & CO.DirectorSep 06, 2024 Sale$15.0315,000,000225,449,99673,822,952Sep 09, 2024, 07:13 PM
WARBURG PINCUS & CO.DirectorSep 06, 2024 Sale$15.0315,000,000225,449,99673,822,952Sep 09, 2024, 07:13 PM
GTCR INVESTMENT XI LLCDirectorSep 06, 2024 Sale$15.0310,000,000150,299,99749,215,301Sep 09, 2024, 05:36 PM
Lyons Jonathan M.Sr. Vice President, CFOAug 05, 2024 Option Exercise$14.227,659108,911110,432Aug 07, 2024, 04:20 PM
WARBURG PINCUS & CO.DirectorMar 04, 2024 Sale$14.3116,594,363237,423,84788,822,952Mar 06, 2024, 05:39 PM
WARBURG PINCUS & CO.DirectorMar 04, 2024 Sale$14.3116,594,363237,423,84788,822,952Mar 06, 2024, 05:38 PM
GTCR INVESTMENT XI LLCDirectorMar 04, 2024 Sale$14.3111,062,908158,282,55559,215,301Mar 06, 2024, 05:35 PM
Klee Ann R.DirectorMar 04, 2024 Sale$14.315,75082,26886,735Mar 06, 2024, 04:41 PM
Rutz Michael PPresident of SterigenicsMar 02, 2024 Option Exercise$14.565,50180,095596,311Mar 05, 2024, 06:06 PM
Rutz Michael PPresident of SterigenicsMar 04, 2024 Sale$14.3183,1091,189,082544,409Mar 05, 2024, 06:06 PM
Petras Michael B. Jr.Chairman & CEOMar 02, 2024 Option Exercise$14.5649,564721,652447,163Mar 05, 2024, 05:35 PM
Petras Michael B. Jr.Chairman & CEOMar 04, 2024 Sale$14.311,003,87014,362,8705,453,580Mar 05, 2024, 05:35 PM
Rutz Michael PPresident of SterigenicsNov 20, 2023 Option Exercise$13.931,91126,620598,749Nov 22, 2023, 04:09 PM
Petras Michael B. Jr.Chairman & CEONov 20, 2023 Option Exercise$13.9329,250407,453555,418Nov 22, 2023, 04:08 PM
Rutz Michael PPresident of SterigenicsMar 02, 2023 Option Exercise$17.412,94851,325572,235Mar 06, 2023, 06:49 PM
Petras Michael B. Jr.Chairman & CEOMar 02, 2023 Option Exercise$17.4119,841345,432371,479Mar 06, 2023, 06:47 PM
Rutz Michael PPresident of SterigenicsNov 20, 2022 Option Exercise$6.021,91111,504575,183Nov 22, 2022, 05:02 PM
Petras Michael B. Jr.Chairman & CEONov 20, 2022 Option Exercise$6.0229,251176,091391,320Nov 22, 2022, 05:00 PM
Leffler Scott J.CFO and TreasurerNov 20, 2021 Option Exercise$22.543,89487,771701,206Nov 23, 2021, 08:00 PM
Petras Michael B. Jr.Chairman & CEONov 20, 2021 Option Exercise$22.5427,517620,233233,352Nov 23, 2021, 08:00 PM
Rutz Michael PPresident of SterigenicsNov 20, 2021 Option Exercise$22.541,91143,074552,132Nov 23, 2021, 07:59 PM
Rutz Michael PPresident of SterigenicsAug 25, 2021 Sale$25.0367,0001,676,876554,043Aug 27, 2021, 05:54 PM
WARBURG PINCUS & CO.DirectorMar 22, 2021 Sale$26.1213,512,582352,982,416105,417,315Mar 24, 2021, 08:58 PM
WARBURG PINCUS & CO.DirectorMar 22, 2021 Sale$26.1213,512,582352,982,416105,417,315Mar 24, 2021, 08:58 PM
GTCR INVESTMENT XI LLCDirectorMar 22, 2021 Sale$26.129,008,388235,321,61170,278,209Mar 24, 2021, 08:57 PM
Klaben Matthew JSVP, GC and SecretaryMar 22, 2021 Sale$26.1241,9521,095,891327,286Mar 24, 2021, 04:39 PM
Petras Michael B. Jr.Chairman & CEOMar 22, 2021 Sale$26.12817,43921,353,5506,377,185Mar 24, 2021, 04:34 PM
Leffler Scott J.CFO and TreasurerNov 24, 2020 Option Exercise$21.68115,3262,500,268705,100Nov 24, 2020, 07:02 PM
Klaben Matthew JSVP, GC and SecretaryNov 24, 2020 Option Exercise$21.6869,1961,500,169369,238Nov 24, 2020, 06:59 PM
Petras Michael B. Jr.Chairman & CEONov 24, 2020 Option Exercise$21.68946,10220,511,4927,194,624Nov 24, 2020, 06:56 PM
Petras Michael B. Jr.Chairman & CEONov 24, 2020 Option Exercise$21.68437,8219,491,9590Nov 24, 2020, 06:56 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
WARBURG PINCUS & CO.Director09/06/2024225,449,996
WARBURG PINCUS & CO.Director09/06/2024225,449,996
GTCR INVESTMENT XI LLCDirector09/06/2024150,299,997
Lyons Jonathan M.Sr. Vice President, CFO08/05/2024108,911
WARBURG PINCUS & CO.Director03/04/2024237,423,847
WARBURG PINCUS & CO.Director03/04/2024237,423,847
GTCR INVESTMENT XI LLCDirector03/04/2024158,282,555
Klee Ann R.Director03/04/202482,268
Rutz Michael PPresident of Sterigenics03/02/202480,095
Rutz Michael PPresident of Sterigenics03/04/20241,189,082
Petras Michael B. Jr.Chairman & CEO03/02/2024721,652
Petras Michael B. Jr.Chairman & CEO03/04/202414,362,870
Rutz Michael PPresident of Sterigenics11/20/202326,620
Petras Michael B. Jr.Chairman & CEO11/20/2023407,453
Rutz Michael PPresident of Sterigenics03/02/202351,325
Petras Michael B. Jr.Chairman & CEO03/02/2023345,432
Rutz Michael PPresident of Sterigenics11/20/202211,504
Petras Michael B. Jr.Chairman & CEO11/20/2022176,091
Leffler Scott J.CFO and Treasurer11/20/202187,771
Petras Michael B. Jr.Chairman & CEO11/20/2021620,233
Rutz Michael PPresident of Sterigenics11/20/202143,074
Rutz Michael PPresident of Sterigenics08/25/20211,676,876
WARBURG PINCUS & CO.Director03/22/2021352,982,416
WARBURG PINCUS & CO.Director03/22/2021352,982,416
GTCR INVESTMENT XI LLCDirector03/22/2021235,321,611
Klaben Matthew JSVP, GC and Secretary03/22/20211,095,891
Petras Michael B. Jr.Chairman & CEO03/22/202121,353,550
Leffler Scott J.CFO and Treasurer11/24/20202,500,268
Klaben Matthew JSVP, GC and Secretary11/24/20201,500,169
Petras Michael B. Jr.Chairman & CEO11/24/202020,511,492
Petras Michael B. Jr.Chairman & CEO11/24/20209,491,959
Load More Insider Transactions
FUNDS WITH A POSITION IN SOTERA HEALTH COMPANY
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.11,428,5770.00307%-1.97%Other
SACHEM HEAD CAPITAL MANAGEMENT LP7,910,0004.67%No changeActivists
MAVERICK CAPITAL LTD3,379,0140.76%-5.27%Growth At A Reasonable Price, Growth
DARSANA CAPITAL PARTNERS LP2,449,3640.79%NewGrowth At A Reasonable Price
GEODE CAPITAL MANAGEMENT, LLC2,308,2050.00241%1.57%Other
LAKEWOOD CAPITAL MANAGEMENT, LP2,307,7392.24%No changeValue
TUDOR INVESTMENT CORP ET AL850,0480.05%-2.77%Event Driven, Other
BALYASNY ASSET MANAGEMENT L.P.558,3030.01%ExitedEvent Driven
AQR CAPITAL MANAGEMENT LLC511,5800.00931%3198.18%Other
GOTHAM ASSET MANAGEMENT, LLC200,4320.03%1580.07%Other
BRANDES INVESTMENT PARTNERS, LP56,4290.00825%301.29%Value
FIRST PACIFIC ADVISORS, LP45,4800.0073%NewValue
FISHER ASSET MANAGEMENT, LLC30,0290.00017%ExitedOther
HBK INVESTMENTS L P12,5000.00071%ExitedEvent Driven
CHANGE IN SHARES OUTSTANDING FOR SOTERA HEALTH COMPANY
STOCK BUYBACKS FOR SOTERA HEALTH COMPANY
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.26%
1Q
03/31/2024
09/30/2023
1.05%
2Q
03/31/2024
06/30/2023
0.32%
3Q
03/31/2024
03/31/2023
0.38%
4Q
03/31/2024
12/31/2022
1.41%
5Q
03/31/2024
09/30/2022
1.39%
6Q
03/31/2024
06/30/2022
1.39%
7Q
03/31/2024
03/31/2022
1.48%
8Q
03/31/2024
12/31/2021
1.53%
9Q
03/31/2024
09/30/2021
1.61%
10Q
03/31/2024
06/30/2021
1.74%
11Q
03/31/2024
03/31/2021
1.83%
12Q
03/31/2024
12/31/2020
12.02%
13Q
03/31/2024
09/30/2020
22.23%
14Q
03/31/2024
06/30/2020
22.23%
15Q
03/31/2024
03/31/2020
22.23%
16Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.26%
1Q
09/30/2023
1.05%
2Q
06/30/2023
0.32%
3Q
03/31/2023
0.38%
4Q
12/31/2022
1.41%
5Q
09/30/2022
1.39%
6Q
06/30/2022
1.39%
7Q
03/31/2022
1.48%
8Q
12/31/2021
1.53%
9Q
09/30/2021
1.61%
10Q
06/30/2021
1.74%
11Q
03/31/2021
1.83%
12Q
12/31/2020
12.02%
13Q
09/30/2020
22.23%
14Q
06/30/2020
22.23%
15Q
03/31/2020
22.23%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SOTERA HEALTH COMPANY
LOADING...